CurrentRheuma
Get Weekly

Topic · page 3 of 17

Systemic sclerosis & Raynaud's

Limited and diffuse systemic sclerosis, skin, lung (interstitial lung disease), pulmonary arterial hypertension, heart, gut and kidney involvement in systemic sclerosis, digital ulcers, primary and secondary Raynaud's phenomenon, very early systemic sclerosis

Briefs 81–120 of 671 placed here, newest publication first

Briefs in Systemic sclerosis & Raynaud's

Newest publication first

  1. RMD Open

    Scoping literature review on applied definitions of very early diagnosis of systemic sclerosis (VEDOSS) and pre-systemic sclerosis in original articles

    Research article

  2. Arthritis Care Res (Hoboken)

    Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort

    Cohort study

  3. Arthritis Res Ther

    Factors associated with variations in the 6-minute walk distance during the follow-up of patients with systemic sclerosis

    Cohort study

  4. Rheumatology (Oxford)

    Coronary microvascular dysfunction in systemic sclerosis: insights from PET-derived myocardial flow reserve

    Cohort study

  5. Arthritis Care Res (Hoboken)

    Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis

    Cohort study

  6. Arthritis Rheumatol

    Skin Transcriptomics Reveal Shared Molecular Mechanisms for Skin and Lung Involvement in Systemic Sclerosis

    Mechanistic study

  7. Semin Arthritis Rheum

    Validity and reliability of hand-held dynamometry for proximal strength assessment in systemic sclerosis-associated myopathy

    Cross-sectional study

  8. Scand J Rheumatol

    Environmental and occupational factors in the aetiopathogenesis of systemic sclerosis: insights from a large multinational patient survey

    Cross-sectional study

  9. Arthritis Care Res (Hoboken)

    Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry

    Cohort study

  10. Lancet Rheumatol

    Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study

    Meta-analysis

  11. J Rheumatol

    Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation

    Cohort study

  12. Rheumatology (Oxford)

    Treatment of systemic sclerosis–associated pulmonary hypertension with and without interstitial lung disease and its impact on survival: a large cohort study of the German network for systemic sclerosis

    Cohort study

  13. Semin Arthritis Rheum

    Clinical relevance of specific and non-specific autoantibodies in systemic sclerosis without overlap features

    Cross-sectional study

  14. Semin Arthritis Rheum

    Systemic sclerosis and small bowel involvement: A systematic review of diagnostic approaches and current evidence

    Meta-analysis

  15. Arthritis Rheumatol

    Long Noncoding RNA H19 Mediates STAT3 ‐Dependent Activation of Keratinocytes and Fibroblasts in Systemic Sclerosis Skin

    Mechanistic study

  16. Rheumatology (Oxford)

    Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud’s phenomenon

    Meta-analysis

  17. Arthritis Care Res (Hoboken)

    Artificial Intelligence–Aided Lung Ultrasound Detection of Interstitial Lung Disease in Systemic Sclerosis and Inflammatory Myopathy

    Diagnostic or prognostic study

  18. Rheumatology (Oxford)

    Clinical characteristics and risk factors for calcinosis cutis in systemic sclerosis: insights from the EUSTAR database

    Cohort study

  19. Rheumatology (Oxford)

    Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous haematopoietic stem cell transplantation: a case series

    Cohort study

  20. Arthritis Rheumatol

    Impact of Evolving Treatment Patterns on Interstitial Lung Disease Progression in Systemic Sclerosis Using the European Scleroderma Trials and Research Database

    Cohort study

  21. Arthritis Rheumatol

    Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

    Cohort study

  22. Clin Exp Rheumatol

    Tracking interstitial lung disease in systemic sclerosis: integrating lung magnetic resonance imaging into a clinically oriented multimodal follow-up strategy

    Cohort study

  23. Arthritis Care Res (Hoboken)

    Differential Item Functioning on the Patient Health Questionnaire 8 by Disease Subtype, Language, Sex, and Age Among People With Systemic Sclerosis: A Scleroderma Patient‐Centered Intervention Network Cohort Study

    Cohort study

  24. Ann Rheum Dis

    Risk score for early mortality to stratify for intensive SSc therapy in the EUSTAR network: the RESIST score

    Diagnostic or prognostic study

  25. Arthritis Rheumatol

    A Cooperative Release of Mitochondrial DNA From Platelets and Neutrophils Drives an Interferon Signature in Systemic Sclerosis

    Mechanistic study

  26. Rheumatology (Oxford)

    Nailfold capillaroscopy improves cardiovascular risk stratification in SSc: an adjustment of the SCORE2 algorithm

    Cohort study

  27. J Rheumatol

    Real-World Adherence to Systemic Sclerosis Quality Indicators: A Single-Center Quality of Care Study

    Cohort study

  28. Semin Arthritis Rheum

    Increased incidence of sudden cardiac death in systemic sclerosis: data from a nationwide cohort study

    Cohort study

  29. Ann Rheum Dis

    Safety and efficacy of blinatumomab in the treatment of refractory systemic sclerosis: a case series

    Cohort study

  30. Semin Arthritis Rheum

    Dermatoscopy limitation and the critical role of capillaroscopy in the evaluation of systemic sclerosis and Raynaud’s phenomenon among African American Veterans

    Diagnostic or prognostic study

  31. Arthritis Rheumatol

    Single‐Cell Profiling Reveals Divergent Mechanisms of Fibrosis in Localized Scleroderma and Systemic Sclerosis

    Mechanistic study

  32. Arthritis Rheumatol

    Antineutrophil Cytoplasmic Antibody–Associated Vasculitides in Systemic Sclerosis: A Unique Clinical Overlap With Significant Implications for Treatment and Outcomes

    Cohort study

  33. Rheumatology (Oxford)

    Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement

    Diagnostic or prognostic study

  34. Rheumatology (Oxford)

    A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot)

    Randomized controlled trial

  35. Arthritis Res Ther

    Prevalence and clinical relevance of systematically tested antimitochondrial antibodies in systemic sclerosis

    Cross-sectional study

  36. Arthritis Rheumatol

    Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes

    Case-control study

  37. RMD Open

    Evaluation of serial cardiovascular magnetic resonance monitoring and immunosuppressive therapy in predicting outcomes in systemic sclerosis

    Cohort study

  38. Semin Arthritis Rheum

    Gastric disease in systemic sclerosis: Spectrum, challenges, and insights from a systematic literature review

    Research article

  39. Rheumatology (Oxford)

    Delayed gastric emptying identifies a high-risk clinical subgroup in patients with systemic sclerosis

    Cohort study

  40. Ann Rheum Dis

    Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis

    Mechanistic study

All 671 Briefs in ExploreShowing Briefs 81–120 of 671, newest first